Medicamentos Inyectables 2023
Se requiere contratar el suministro de Medicamentos Inyectables 2023 requerido para los tratamientos de los pacientes beneficiarios, atendidos en el Hospital de Tomé, de acuerdo a lo indicado por el profesional clínico.
17 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058131-205-SE26 | 17-06-2026 | Megalabs Chile S.A. | $451.177 |
| 1058131-175-SE26 | 20-05-2026 | Megalabs Chile S.A. | $601.569 |
| 1058131-105-SE26 | 06-03-2026 | Megalabs Chile S.A. | $601.569 |
| 1058131-19-SE26 | 14-01-2026 | Farmaceutica Caribean SpA | $145.347 |
| 1058131-16-SE26 | 14-01-2026 | Megalabs Chile S.A. | $601.569 |
| 1058131-704-SE25 | 22-12-2025 | Megalabs Chile S.A. | $300.784 |
| 1058131-655-SE25 | 20-11-2025 | Laboratorio Sanderson S.A. | $88.774 |
| 1058131-633-SE25 | 24-10-2025 | Insuamérica SpA | $414.120 |
| 1058131-620-SE25 | 22-10-2025 | Megalabs Chile S.A. | $300.784 |
| 1058131-598-SE25 | 15-10-2025 | Laboratorio Sanderson S.A. | $88.536 |
| 1058131-557-SE25 | 03-10-2025 | Megalabs Chile S.A. | $300.784 |
| 1058131-496-SE25 | 09-09-2025 | Megalabs Chile S.A. | $300.784 |
| 1058131-436-SE25 | 07-08-2025 | Megalabs Chile S.A. | $451.177 |
| 1058131-429-SE25 | 05-08-2025 | Insuamérica SpA | $552.160 |
| 1058131-382-SE25 | 07-07-2025 | Laboratorio Sanderson S.A. | $133.161 |
| 1058131-368-SE25 | 17-06-2025 | Megalabs Chile S.A. | $451.177 |
| 1058131-320-SE25 | 29-05-2025 | Megalabs Chile S.A. | $451.177 |
| 1058131-221-SE25 | 02-04-2025 | Megalabs Chile S.A. | $300.784 |
| 1058131-214-SE25 | 31-03-2025 | Farmaceutica Caribean SpA | $87.786 |
| 1058131-210-SE25 | 31-03-2025 | Laboratorio Sanderson S.A. | $88.774 |
| 1058131-127-SE25 | 18-02-2025 | Megalabs Chile S.A. | $751.961 |
| 1058131-118-SE25 | 07-02-2025 | Insuamérica SpA | $552.160 |
| 1058131-85-SE25 | 28-01-2025 | Insuamérica SpA | $414.120 |
| 1058131-24-SE25 | 17-01-2025 | Megalabs Chile S.A. | $451.177 |
| 1058131-32-SE25 | 17-01-2025 | Ascend Laboratories SpA | $257.040 |
| 1058131-800-SE24 | 06-12-2024 | Megalabs Chile S.A. | $451.177 |
| 1058131-804-SE24 | 06-12-2024 | Laboratorio Biosano S.A. | $224.910 |
| 1058131-723-SE24 | 11-11-2024 | Megalabs Chile S.A. | $375.981 |
| 1058131-684-SE24 | 10-10-2024 | Insuamérica SpA | $414.120 |
| 1058131-664-SE24 | 03-10-2024 | Megalabs Chile S.A. | $300.784 |
| 1058131-652-SE24 | 02-10-2024 | Ascend Laboratories SpA | $257.040 |
| 1058131-640-SE24 | 01-10-2024 | Laboratorio Sanderson S.A. | $148.750 |
| 1058131-586-SE24 | 02-09-2024 | Insuamérica SpA | $552.160 |
| 1058131-565-SE24 | 29-08-2024 | Megalabs Chile S.A. | $375.981 |
| 1058131-490-SE24 | 02-08-2024 | Megalabs Chile S.A. | $300.784 |
| 1058131-324-SE24 | 28-05-2024 | Laboratorio Sanderson S.A. | $88.774 |
| 1058131-308-SE24 | 15-05-2024 | Megalabs Chile S.A. | $451.177 |
| 1058131-276-SE24 | 30-04-2024 | Ascend Laboratories SpA | $257.040 |
| 1058131-255-SE24 | 29-04-2024 | Megalabs Chile S.A. | $419.784 |
| 1058131-164-SE24 | 27-02-2024 | Megalabs Chile S.A. | $375.981 |
| 1058131-82-SE24 | 29-01-2024 | Megalabs Chile S.A. | $300.784 |
| 1058131-61-SE24 | 25-01-2024 | Laboratorio Sanderson S.A. | $168.147 |
| 1058131-793-SE23 | 07-12-2023 | Megalabs Chile S.A. | $300.784 |
| 1058131-780-SE23 | 06-12-2023 | Laboratorio Sanderson S.A. | $88.774 |
| 1058131-739-SE23 | 14-11-2023 | Insuamérica SpA | $414.120 |
| 1058131-709-SE23 | 13-11-2023 | Farmaceutica Caribean SpA | $72.673 |
| 1058131-679-SE23 | 07-11-2023 | Megalabs Chile S.A. | $300.784 |
| 1058131-629-SE23 | 31-08-2023 | Insuamérica SpA | $207.060 |
| 1058131-604-SE23 | 23-08-2023 | Laboratorio Sanderson S.A. | $242.522 |
| 1058131-584-SE23 | 16-08-2023 | Megalabs Chile S.A. | $300.784 |
| 1058131-531-SE23 | 12-07-2023 | Opko Chile S.A. | $194.565 |
| 1058131-481-SE23 | 16-06-2023 | Farmaceutica Caribean SpA | $145.347 |
| 1058131-498-SE23 | 16-06-2023 | Laboratorio Sanderson S.A. | $44.268 |
| 1058131-493-SE23 | 16-06-2023 | Laboratorio Biosano S.A. | $107.100 |
| 1058131-488-SE23 | 16-06-2023 | Laboratorio Sanderson S.A. | $148.750 |
| 1058131-473-SE23 | 14-06-2023 | Megalabs Chile S.A. | $451.177 |
| 1058131-447-SE23 | 31-05-2023 | Laboratorio Sanderson S.A. | $61.975 |
| 1058131-442-SE23 | 29-05-2023 | Laboratorio Biosano S.A. | $160.650 |
| 1058131-394-SE23 | 23-05-2023 | Farmaceutica Caribean SpA | $728.387 |
| 1058131-405-SE23 | 23-05-2023 | Laboratorio Sanderson S.A. | $196.350 |
| 1058131-393-SE23 | 23-05-2023 | Insuamérica SpA | $552.160 |
| 1058131-374-SE23 | 19-05-2023 | Ascend Laboratories SpA | $385.560 |
Fuente original:ficha mercadopublico.cl
